Catalyst Pharmaceuticals Statistics
Total Valuation
CPRX has a market cap or net worth of $1.74 billion. The enterprise value is $1.60 billion.
| Market Cap | 1.74B |
| Enterprise Value | 1.60B |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CPRX has 117.86 million shares outstanding. The number of shares has increased by 2.13% in one year.
| Shares Outstanding | 117.86M |
| Shares Change (YoY) | +2.13% |
| Shares Change (QoQ) | +6.75% |
| Owned by Insiders (%) | 6.21% |
| Owned by Institutions (%) | 73.33% |
| Float | 101.66M |
Valuation Ratios
The trailing PE ratio is 23.44 and the forward PE ratio is 14.00.
| PE Ratio | 23.44 |
| Forward PE | 14.00 |
| PS Ratio | 4.35 |
| Forward PS | 3.66 |
| PB Ratio | 4.46 |
| P/FCF Ratio | 12.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.50, with an EV/FCF ratio of 11.13.
| EV / Earnings | 22.35 |
| EV / Sales | 4.01 |
| EV / EBITDA | 12.50 |
| EV / EBIT | 16.88 |
| EV / FCF | 11.13 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.88 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 19.80% and return on invested capital (ROIC) is 16.77%.
| Return on Equity (ROE) | 19.80% |
| Return on Assets (ROA) | 16.50% |
| Return on Capital (ROIC) | 16.77% |
| Revenue Per Employee | $2.38M |
| Profits Per Employee | $427,605 |
| Employee Count | 167 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 4.63 |
Taxes
In the past 12 months, CPRX has paid $23.10 million in taxes.
| Income Tax | 23.10M |
| Effective Tax Rate | 24.44% |
Stock Price Statistics
The stock price has decreased by -8.76% in the last 52 weeks. The beta is 0.88, so CPRX's price volatility has been lower than the market average.
| Beta (1Y) | 0.88 |
| 52-Week Price Change | -8.76% |
| 50-Day Moving Average | 15.47 |
| 200-Day Moving Average | 14.20 |
| Relative Strength Index (RSI) | 41.25 |
| Average Volume (30 Days) | 1,344,224 |
Short Selling Information
The latest short interest is 6.27 million, so 5.32% of the outstanding shares have been sold short.
| Short Interest | 6.27M |
| Short Previous Month | 6.05M |
| Short % of Shares Out | 5.32% |
| Short % of Float | 6.17% |
| Short Ratio (days to cover) | 3.91 |
Income Statement
In the last 12 months, CPRX had revenue of $398.20 million and earned $71.41 million in profits. Earnings per share was $0.63.
| Revenue | 398.20M |
| Gross Profit | 346.24M |
| Operating Income | 86.81M |
| Pretax Income | 94.51M |
| Net Income | 71.41M |
| EBITDA | 127.65M |
| EBIT | 94.51M |
| Earnings Per Share (EPS) | $0.63 |
Balance Sheet
The company has $137.64 million in cash and $3.19 million in debt, giving a net cash position of $134.45 million or $1.14 per share.
| Cash & Cash Equivalents | 137.64M |
| Total Debt | 3.19M |
| Net Cash | 134.45M |
| Net Cash Per Share | $1.14 |
| Equity / Book Value | 387.88M |
| Book Value Per Share | 3.29 |
| Working Capital | 143.27M |
Cash Flow
In the last 12 months, operating cash flow was $143.60 million and capital expenditures -$231,000, giving a free cash flow of $143.37 million.
| Operating Cash Flow | 143.60M |
| Capital Expenditures | -231,000 |
| Free Cash Flow | 143.37M |
| FCF Per Share | $1.35 |
Margins
Gross margin is 86.95%, with operating and profit margins of 21.80% and 17.93%.
| Gross Margin | 86.95% |
| Operating Margin | 21.80% |
| Pretax Margin | 23.73% |
| Profit Margin | 17.93% |
| EBITDA Margin | 32.06% |
| EBIT Margin | 23.73% |
| FCF Margin | 36.00% |
Dividends & Yields
CPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.13% |
| Shareholder Yield | -2.13% |
| Earnings Yield | 4.13% |
| FCF Yield | 8.29% |
Analyst Forecast
The average price target for CPRX is $26.83, which is 81.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.83 |
| Price Target Difference | 81.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 7.01% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CPRX has an Altman Z-Score of 14.86 and a Piotroski F-Score of 7.
| Altman Z-Score | 14.86 |
| Piotroski F-Score | 7 |